Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhao, Caiqi ^a   Su, Emily M ^b   Yang, Xi ^a   Gao, Zhaowei ^a   Li, Ling ^a   Wu, Haiya ^a   Jiang, Yiyi ^a   Su, Xiao ^a,b  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOTOXIN; LIPOPOLYSACCHARIDE; P SELECTIN GLYCOPROTEIN LIGAND 1; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENDOTOXIN INDUCED LUNG INFLAMMATION; GENE MUTATION; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; WILD TYPE;

ANIMALS; BLOOD PLATELETS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOTOXINS; FLOW CYTOMETRY; MEMBRANE GLYCOPROTEINS; MICE; PLATELET ACTIVATING FACTOR; PNEUMONIA;

EID: 84893189031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082683     Document Type: Article

References (23)

1. Su X, Looney MR, Su HE, Lee JW, Song Y, et al. (2011) Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice. Inflamm Res 60: 619-632.
2. Mattoscio D, Evangelista V, De Cristofaro R, Recchiuti A, Pandolfi A, et al. (2010) Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J 24: 3970-3980.
3. Ciabattoni G, Davi G, Collura M, Iapichino L, Pardo F, et al. (2000) In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 162: 1195-1201.
4. O'Sullivan BP, Linden MD, Frelinger AL 3rd, Barnard MR, Spencer-Manzon M, et al. (2005) Platelet activation in cystic fibrosis. Blood 105: 4635-4641. (Pubitemid 40807282)
5. O'Sullivan BP, Michelson AD (2006) The inflammatory role of platelets in cystic fibrosis. Am J Respir Crit Care Med 173: 483-490.
6. Konstan MW, Byard PJ, Hoppel CL, Davis PB (1995) Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332: 848-854.
7. Lands LC, Milner R, Cantin AM, Manson D, Corey M (2007) High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. J Pediatr 151: 249-254. (Pubitemid 47284135)
8. Vandendries ER, Furie BC, Furie B (2004) Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92: 459-466. (Pubitemid 39248002)
9. Kuster LJ, Filep J, Frolich JC (1986) Mechanism of PAF-induced platelet aggregation in man. Thromb Res 43: 425-433. (Pubitemid 16064358)
10. Song Y, Sonawane ND, Salinas D, Qian L, Pedemonte N, et al. (2004) Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem 279: 40629-40633. (Pubitemid 39287655)
11. Su X, Looney M, Robriquet L, Fang X, Matthay MA (2004) Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice. Exp Lung Res 30: 479-493. (Pubitemid 39096096)
12. Qian F, Deng J, Cheng N, Welch EJ, Zhang Y, et al. (2009) A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury. EMBO J 28: 2896-2907.
13. Jacquot J, Tabary O, Clement A (2008) Hyperinflammation in airways of cystic fibrosis patients: what's new? Expert Rev Mol Diagn 8: 359-363. (Pubitemid 351962082)
14. Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, et al. (2009) Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A 106: 5779-5783.
15. Yang J, Hirata T, Croce K, Merrill-Skoloff G, Tchernychev B, et al. (1999) Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 190: 1769-1782. (Pubitemid 30013843)
16. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, et al. (2000) P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 191: 1413-1422. (Pubitemid 30227127)
17. Furie B, Furie BC (2004) Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 10: 171-178. (Pubitemid 38410975)
18. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM (2002) The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30: S294-301. (Pubitemid 34508006)
19. Chang SW, Feddersen CO, Henson PM, Voelkel NF (1987) Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 79: 1498-1509. (Pubitemid 17099656)
20. Beijer L, Botting J, Crook P, Oyekan AO, Page CP, et al. (1987) The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig. Br J Pharmacol 92: 803-808. (Pubitemid 18014930)
21. Rabinovici R, Esser KM, Lysko PG, Yue TL, Griswold DE, et al. (1991) Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res 69: 12-25.
22. Stead RJ, Barradas MA, Mikhailidis DP, Jeremy JY, Hodson ME, et al. (1987) Platelet hyperaggregability in cystic fibrosis. Prostaglandins Leukot Med 26: 91-103. (Pubitemid 17019085)
23. Robert R, Carlile GW, Pavel C, Liu N, Anjos SM, et al. (2008) Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect. Mol Pharmacol 73: 478-489. (Pubitemid 351159218)